# Developing Objective Measures of Levodopa Induced Dyskinesia: (Study 1)

> **NCT00467597** · — · COMPLETED · sponsor: **US Department of Veterans Affairs** · enrollment: 36 (actual)

## Conditions studied

- Dyskinesias
- Movement Disorders
- Parkinson Disease

## Interventions

- **DRUG:** Levodopa (delivered intravenously)

## Key facts

- **NCT ID:** NCT00467597
- **Lead sponsor:** US Department of Veterans Affairs
- **Sponsor class:** FED
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2008-08
- **Final completion:** 2013-10
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2014-11-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00467597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00467597, "Developing Objective Measures of Levodopa Induced Dyskinesia: (Study 1)". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00467597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*